BIOMAT Database Logo BIOMAT Database Logo

[Intensain treatment of acute coronary insufficiency]. 1970

B E Votchal, and L G Lozinskiĭ

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D006016 Glycolates Derivatives of ACETIC ACID which contain an hydroxy group attached to the methyl carbon. 2-Hydroxyacetates,Glycolate Ethers,Hydroxyacetate Ethers,Hydroxyacetates,Hydroxyacetic Acids,2 Hydroxyacetates,Acids, Hydroxyacetic,Ethers, Glycolate,Ethers, Hydroxyacetate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator
D014700 Verapamil A calcium channel blocker that is a class IV anti-arrhythmia agent. Iproveratril,Calan,Cordilox,Dexverapamil,Falicard,Finoptin,Isoptin,Isoptine,Izoptin,Lekoptin,Verapamil Hydrochloride,Hydrochloride, Verapamil

Related Publications

B E Votchal, and L G Lozinskiĭ
[TREATMENT OF CORONARY INSUFFICIENCY WITH INTENSAIN].
June 1964, Munchener medizinische Wochenschrift (1950),
B E Votchal, and L G Lozinskiĭ
[Treatment of heart and coronary insufficiency with Intensain Lanicor].
May 1966, Munchener medizinische Wochenschrift (1950),
B E Votchal, and L G Lozinskiĭ
[Prolonged intensain treatment of chronic coronary insufficiency under ambulatory conditions].
July 1971, Kardiologiia,
B E Votchal, and L G Lozinskiĭ
[Therapy of severe coronary insufficiency with Intensain].
September 1968, Die Medizinische Welt,
B E Votchal, and L G Lozinskiĭ
[The effect of intensain on electrocardiographic and clinical manifestations of acute coronary insufficiency].
January 1968, Semaine therapeutique,
B E Votchal, and L G Lozinskiĭ
[Treatment of heart insufficiency with Intensain-Lanicor].
June 1968, Deutsches medizinisches Journal,
B E Votchal, and L G Lozinskiĭ
[New data on the action of intensain in coronary and myocardial insufficiency].
May 1969, Kardiologiia,
B E Votchal, and L G Lozinskiĭ
[Treatment of coronary insufficiency in diabetics: Part 2: acute coronary insufficiency].
February 1999, Annales de cardiologie et d'angeiologie,
B E Votchal, and L G Lozinskiĭ
[Surgical treatment of acute coronary insufficiency].
January 1966, Grudnaia khirurgiia (Moscow, Russia),
B E Votchal, and L G Lozinskiĭ
[Results of a clinical study of the therapeutic effect of intensain in chronic coronary insufficiency].
February 1969, Kardiologiia,
Copied contents to your clipboard!